Therapeutic delivery of carbon monoxide

Details Therapeutic delivery of carbon monoxide Therapeutic delivery of carbon monoxide

2006-05-16

2006-05-16

Azpuru, Carlos A. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

C424S434000, C424S435000, C424S436000, C424S451000, C424S464000

Reexamination Certificate

active

07045140

ABSTRACT:
Metal carbonyls are used to deliver CO having biological activity, for example vasodilatation and inhibition of transplant rejection. The metal of the carbonyl is typically of groups 7 to 10, e.g. Fe and Ru. The carbonyl preferably has one or more ligands other than CO, such as amino acids, to modulate the CO release property and solubility.

REFERENCES:
patent: 5882674 (1999-03-01), Herrmann et al.
patent: 2002/0155166 (2002-10-01), Choi et al.
patent: 211 084 (1990-04-01), None
patent: WO 91/01128 (1991-02-01), None
patent: WO 91/01301 (1991-02-01), None
patent: WO 94/22482 (1994-10-01), None
patent: WO 95/05814 (1995-03-01), None
patent: WO 98/29115 (1998-07-01), None
patent: WO 98/48848 (1998-11-01), None
patent: WO 00/56743 (2000-09-01), None
patent: WO 02/078684 (2002-10-01), None
patent: WO 02/080923 (2002-10-01), None
patent: WO 03/000114 (2003-01-01), None
patent: WO 03/0666067 (2003-08-01), None
patent: WO 03/072024 (2003-09-01), None
patent: WO 03/088923 (2003-10-01), None
patent: WO 03/088981 (2003-10-01), None
patent: WO 03/094932 (2003-11-01), None
Furchgott, et al, Blood Vessels 1991;28:52-61 “Endothelium-Dependent and -Independent Vasodilation Involving Cyclic GMP: Relaxation Induced by Nitric Oxide, Carbon Monoxide and Light”.
Wang et al, Biochemistry, vol. 18, No. 22, 1979, 4960-4977 “A Correlation of the Visible and Soret Spectra of Dioxygen- and Carbon Monoxide-Heme Complexes and Five-Coordinate Heme Complexes with the Spectra of Oxy-, Carboxy-, and Deoxyhemoglobins”.
Schubert, Nov., 1933 Carbon Monoxide on Iron and Cobalt Cysteine Complexes, vol. 55, 4563-4570 “The Action of Carbon Monoxide on Iron and Cobalt Complexes of Cysteine”.
Carroll et al, Can. J. Chem. vol. 52, 1974, 1914-1922 “Ligand Abstraction in the Reaction of Aryldiazonium Ions with some Iron Complexes Containing Coordinated Cysteine, Maleonitriledithiol, or Triarylphosphine”.
Sjöstrand, Scan. J. Clin. Lab Invest., 1949, 1:201-214 “Endogenous Formation of Carbon Monoxide In Man Under Normal and Pathological Conditions”.
Coburn et al, J. of Clinical Investigation, vol. 42, No. 7, 1963, 1172-1178 “Endogenous Carbon Monoxide Production in Man”.
Tenhunen et al, J. of Biological Chemistry, vol. 244, No. 23, 6388-6394 (1969) “Microsomal Heme Oxygenase”.
Maines, Dept. of Biophysics, University of Rochester, FASEB J 2:2557-2568 (1988) “Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications”.
Morita et al, Proc. Natl. Acad. Sci. USA, Cell Biology, 1995, vol. 92, 1475-1479, “Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP”.
Sammut et al, British J. of Pharmacology, 1998, 125, 1437-1444 “Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1”.
Maines, Annu. Rev., Pharmacol. Toxocol, 1997, 517-554, “The Heme Oxygenase System: A Regulator of Second Messenger Gases”.
Soares et al, Nature Medicine, vol. 4, No. 9, 1998, 1073-1077, “Expression of heme oxygenase-1 can determine cardiac xenograft survival”.
Willis et al, Nature Medicine, vol. 2, No. 1, 1996, 87-90 “Heme oxygenase: A novel target for the modulation of the inflammatory response”.
Motterlini et al, Regulation of Pressor Responses by HO-1-Derived CO, 1998, 568-577 “Heme Oxygenase-1-Derived Carbon Monoxide Contributes to the Suppression of Acute Hypertensive Responses In Vivo”.
Otterbein et al, Am. J. Physiol., 1999, 688-694 Carbon monoxide provides protection against hyperoxic lung injury.
Otterbein et al, J. Clin. Invest., 103; 1047-1054, 1999, “Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury”.
Herrick et al, Inorg. Chem. 1984, 23, 4550-4553 “Flash Photolytic Investigation of Photoinduced Carbon Monoxide Dissociation from Dinuclear Manganese Carbonyl Compounds”.
Alessio et al, Inorg. Chem., 1995, 34, 4722-4734 “Carbonyl Derivatives of Chloride-Dimethyl Sulfoxide-Ruthenium (II) Complexes: Synthesis, Structural Characterization, and Reactivity of RU(CO)x(DMSO)4−xCI2Complexes (x=1-3)”.
Sato et al, The J. of Immunology, 2001, 4185-4195, “Carbon Monoxide Generated by Heme Oxygenase-1 Suppresses the Rejection of Mouse-to-Rat Cardiac Transplants”.
Pneumatikakis et al, Inorganica Chimica Acta, 151, 1988, 243-248 “Interactions of Bis-[μ-chloro-chlorotricarbonylruthenium(II) and poly-[μ-dichloro-dicarbonylruthenium (II] with Nucleotides”.
Yan et al, Pharmazie, 2000, 55(4), 307-313 “Cytotoxicity of rhenium (I) alkoxo and hydroxo carbonyl complexes in murin and human tumor cells”.
Becker et al, Medical Sciences (1979), vol. 15, No. 2, 147-150, “Age related changes in antibody dependent cell mediated cytotoxicity in mouse spleen”.
Nagai et al., Biochemistry, 1991, vol. 30, No. 26, 6495-6503, “Unusual CO Bonding Geometry in Abnormal Subunits of Hemoglobin M Boston and Hemoglobin M Saskatoon”.
Tomita et al., Inorganic and Nuclear Chemistry Letters 1968, vol. 4, 715-718 “Structure and Reaction of Bis(L-cysteinato)Dicarbonyliron(II)”.
Ferrier et al, J. of Molecular Structure 344, 1995, 189-193 “FTIR spectrometric study of geometrical isomers of dicarbonyl ferrobiscysteinate Influence of the counter cation”.
Szakács-Schmidt et al, Inorganica Chimica Acta, 198-200, 1992, 401-405 “Iron (II) thiolates as reversible-carbon monoxide carriers”.
Takács et al, Inorganic Chimica Acta, 166, 1989, 39-46 “Synthesis and Molecular Structure of Carbonyl Derivatives of Iron(II) Thiolates Containing Nitrogen-donor Ligands”.
Tomita et al, Inorg. Nucl. Chem. Letters vol. 4, 715-718, 1968, “Structure and Reaction of Bis(L-cysteinato)Dicarbonyliron(II)”.
Huang et al, J. Am. Chem. Soc., 1991, 113, 9141-9144 “Photolysis of the Histidine-Heme-CO Complex”.
Silver et al, Inorganica Chimica Acta, 91, 1984, 279-283 “Mossbauer Studies on Protoprophyrin IX Iron(II) Solutions Containing Sulphur Ligands and their Carbonyl Adducts. Models for the Active Site of Cytochromes P-450”.
Diamantis et al, Inorg. Chem., 1981, 20, 1141-1150 Preparation and Structure of Ethylenediaminetetraacetate Complexes of Ruthenium(II) with Dinitrogen, Carbon Monoxide, and other π-Acceptor Ligands.
Urban et al, J. of Organometallic Chemistry 517, 1996, 191-200 Metal complexes of biologically important ligands, LXXXVII α-Amino carboxylate complexes of palladium(II), iridium(III) and ruthenium(II) from chloro-bridged ortho-metallated metal compounds and [(OC)3Ru(Cl)(μ-Cl)]2.
Motterlini et al, Carbon Monoxide-Releasing Molecules: Characterization Of Biomedical And Vascular Activities, Circulation Research. 2002, vol. 90, No. 2, 1-8.
Motterlini, R. et al.; “Characterization of vasoactive effects elicited by carbon monoxide-releasing molecules,”; Journal of Vascular Research, Abstracts, 8thInternational Symposium on Mechanisms of Vasodilation; May 31—Jun. 3, 2001; 055.
Durante W.; “Heme Oxygenase-1 in Growth Control and its Clinical Application to Vascular Disease”; J. Cell. Physiol.; 2003; 195; 373-82.
Gordeuk, V. P. et al; “Carbonyl Iron Therapy for Iron Deficiency Anemia”; Blood; 1986; 67(3); 745-752.
Huebers, H. A. et al.; “Absorption of carbonyl iron”; J. Lab. Clin. Med.; 1986; 108; 473-8.
Sacks, P. V. et al.; “Comparative bioavailability of elemental iron powders for repair of iron deficiency anemia in rats. Studies of efficacy and toxicity of carbonyl iron”; The American Journal of Clinical Nutrition, 1978; 31;566-73.

Affiliated with

Also associated with

Rating

Therapeutic delivery of carbon monoxide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic delivery of carbon monoxide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic delivery of carbon monoxide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3556480